Evidence map›Paper›PMID 42140897›Full record

ArticleNature communications2026

A Bayesian modelling framework to improve antibody titer estimation applied to RSV dilution series data.

Yan Wang, Qianli Wang, Chris Wymant, Junyi Zou, Lan Yi, Meng Xu, James A Hay, Hongjie Yu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yan WangSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.ORCID http://orcid.org/0000-0002-5620-2328
Qianli WangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Chris WymantPandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-9847-8226
Junyi ZouSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Lan YiShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Meng XuSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
James A HayPandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. james.hay@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0002-1998-1844
Hongjie YuSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China. yhj@fudan.edu.cn.ORCID http://orcid.org/0000-0002-6335-5648

Funding

China Postdoctoral Science Foundation 2024M750556Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2025ZD01901300Wellcome TrustWellcome Trust (Wellcome) 225001/Z/22/Z
6 · The paper itself

Abstract

Accurately measuring antibody levels is important for assessing population immunity and guiding vaccine development. We identify batch-level biases and experimental noise in neutralizing antibody (nAb) titer estimates from respiratory syncytial virus (RSV) foci reduction neutralization tests (FRNTs) when using off-the-shelf methods such as the Kärber formula and four-parameter logistic (4PL) model. To address this, we develop a Bayesian hierarchical model (BHM) to estimate nAb titers, correcting for batch effects and other sources of experimental variation. We evaluate model performance using both simulated and experimental FRNT data. In simulation, nAb titers are most accurate using the BHM (Spearman

Indexed as

Antibodies, NeutralizingAntibodies, ViralRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsAnimalsBayes TheoremComputer SimulationHumansNeutralization TestsAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID42140897
PMCPMC13377111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.